195 related articles for article (PubMed ID: 11404817)
81. Fine mapping of 10q and 18q for familial Alzheimer's disease in Caribbean Hispanics.
Lee JH; Mayeux R; Mayo D; Mo J; Santana V; Williamson J; Flaquer A; Ciappa A; Rondon H; Estevez P; Lantigua R; Kawarai T; Toulina A; Medrano M; Torres M; Stern Y; Tycko B; Rogaeva E; St George-Hyslop P; Knowles JA
Mol Psychiatry; 2004 Nov; 9(11):1042-51. PubMed ID: 15241431
[TBL] [Abstract][Full Text] [Related]
82. Results of a genome-wide linkage analysis in prostate cancer families ascertained through the ACTANE consortium.
Edwards S; Meitz J; Eles R; Evans C; Easton D; Hopper J; Giles G; Foulkes WD; Narod S; Simard J; Badzioch M; Mahle L;
Prostate; 2003 Dec; 57(4):270-9. PubMed ID: 14601023
[TBL] [Abstract][Full Text] [Related]
83. Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus.
Grönberg H; Isaacs SD; Smith JR; Carpten JD; Bova GS; Freije D; Xu J; Meyers DA; Collins FS; Trent JM; Walsh PC; Isaacs WB
JAMA; 1997 Oct; 278(15):1251-5. PubMed ID: 9333266
[TBL] [Abstract][Full Text] [Related]
84. Comparison of microsatellites versus single-nucleotide polymorphisms in a genome linkage screen for prostate cancer-susceptibility Loci.
Schaid DJ; Guenther JC; Christensen GB; Hebbring S; Rosenow C; Hilker CA; McDonnell SK; Cunningham JM; Slager SL; Blute ML; Thibodeau SN
Am J Hum Genet; 2004 Dec; 75(6):948-65. PubMed ID: 15514889
[TBL] [Abstract][Full Text] [Related]
85. Linkage and association of CYP17 gene in hereditary and sporadic prostate cancer.
Chang B; Zheng SL; Isaacs SD; Wiley KE; Carpten JD; Hawkins GA; Bleecker ER; Walsh PC; Trent JM; Meyers DA; Isaacs WB; Xu J
Int J Cancer; 2001 Nov; 95(6):354-9. PubMed ID: 11668516
[TBL] [Abstract][Full Text] [Related]
86. Suggestive genetic linkage to chromosome 11p11.2-q12.2 in hereditary prostate cancer families with primary kidney cancer.
Johanneson B; Deutsch K; McIntosh L; Friedrichsen-Karyadi DM; Janer M; Kwon EM; Iwasaki L; Hood L; Ostrander EA; Stanford JL
Prostate; 2007 May; 67(7):732-42. PubMed ID: 17372923
[TBL] [Abstract][Full Text] [Related]
87. Evidence for a prostate cancer susceptibility locus on the X chromosome.
Xu J; Meyers D; Freije D; Isaacs S; Wiley K; Nusskern D; Ewing C; Wilkens E; Bujnovszky P; Bova GS; Walsh P; Isaacs W; Schleutker J; Matikainen M; Tammela T; Visakorpi T; Kallioniemi OP; Berry R; Schaid D; French A; McDonnell S; Schroeder J; Blute M; Thibodeau S; Grönberg H; Emanuelsson M; Damber JE; Bergh A; Jonsson BA; Smith J; Bailey-Wilson J; Carpten J; Stephan D; Gillanders E; Amundson I; Kainu T; Freas-Lutz D; Baffoe-Bonnie A; Van Aucken A; Sood R; Collins F; Brownstein M; Trent J
Nat Genet; 1998 Oct; 20(2):175-9. PubMed ID: 9771711
[TBL] [Abstract][Full Text] [Related]
88. Genome-wide linkage analysis of 723 affected relative pairs with late-onset Alzheimer's disease.
Hamshere ML; Holmans PA; Avramopoulos D; Bassett SS; Blacker D; Bertram L; Wiener H; Rochberg N; Tanzi RE; Myers A; Wavrant-De Vrièze F; Go R; Fallin D; Lovestone S; Hardy J; Goate A; O'Donovan M; Williams J; Owen MJ
Hum Mol Genet; 2007 Nov; 16(22):2703-12. PubMed ID: 17725986
[TBL] [Abstract][Full Text] [Related]
89. PCAP is the major known prostate cancer predisposing locus in families from south and west Europe.
Cancel-Tassin G; Latil A; Valéri A; Mangin P; Fournier G; Berthon P; Cussenot O
Eur J Hum Genet; 2001 Feb; 9(2):135-42. PubMed ID: 11313747
[TBL] [Abstract][Full Text] [Related]
90. Where are the prostate cancer genes?--A summary of eight genome wide searches.
Easton DF; Schaid DJ; Whittemore AS; Isaacs WJ;
Prostate; 2003 Dec; 57(4):261-9. PubMed ID: 14601022
[TBL] [Abstract][Full Text] [Related]
91. Genetic linkage analysis of prostate cancer families to Xq27-28.
Peters MA; Jarvik GP; Janer M; Chakrabarti L; Kolb S; Goode EL; Gibbs M; DuBois CC; Schuster EF; Hood L; Ostrander EA; Stanford JL
Hum Hered; 2001; 51(1-2):107-13. PubMed ID: 11096277
[TBL] [Abstract][Full Text] [Related]
92. Analysis of HPC1, HPCX, and PCaP in Icelandic hereditary prostate cancer.
Bergthorsson JT; Johannesdottir G; Arason A; Benediktsdottir KR; Agnarsson BA; Bailey-Wilson JE; Gillanders E; Smith J; Trent J; Barkardottir RB
Hum Genet; 2000 Oct; 107(4):372-5. PubMed ID: 11129338
[TBL] [Abstract][Full Text] [Related]
93. Genome-wide linkage scan for psoriasis susceptibility loci in multiplex Tunisian families.
Ammar M; Bouchlaka-Souissi C; Helms CA; Zaraa I; Jordan CT; Anbunathan H; Bouhaha R; Kouidhi S; Doss N; Dhaoui R; Ben Osman A; Ben Ammar El Gaied A; Marrakchi R; Mokni M; Bowcock AM
Br J Dermatol; 2013 Mar; 168(3):583-7. PubMed ID: 23013406
[TBL] [Abstract][Full Text] [Related]
94. Genome-wide linkage scan for prostate cancer aggressiveness loci using families from the University of Michigan Prostate Cancer Genetics Project.
Slager SL; Zarfas KE; Brown WM; Lange EM; McDonnell SK; Wojno KJ; Cooney KA
Prostate; 2006 Feb; 66(2):173-9. PubMed ID: 16173044
[TBL] [Abstract][Full Text] [Related]
95. Long Non-Coding RNAs at the Chromosomal Risk Loci Identified by Prostate and Breast Cancer GWAS.
Janaththani P; Srinivasan SL; Batra J
Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946977
[TBL] [Abstract][Full Text] [Related]
96.
Faisal FA; Murali S; Kaur H; Vidotto T; Guedes LB; Salles DC; Kothari V; Tosoian JJ; Han S; Hovelson DH; Hu K; Spratt DE; Baras AS; Tomlins SA; Schaeffer EM; Lotan TL
Clin Cancer Res; 2020 Jun; 26(11):2595-2602. PubMed ID: 31969336
[TBL] [Abstract][Full Text] [Related]
97. Data-adaptive multi-locus association testing in subjects with arbitrary genealogical relationships.
Gong G; Wang W; Hsieh CL; Van Den Berg DJ; Haiman C; Oakley-Girvan I; Whittemore AS
Stat Appl Genet Mol Biol; 2019 Apr; 18(3):. PubMed ID: 30956231
[TBL] [Abstract][Full Text] [Related]
98. A New Combinatorial Optimization Approach for Integrated Feature Selection Using Different Datasets: A Prostate Cancer Transcriptomic Study.
Puthiyedth N; Riveros C; Berretta R; Moscato P
PLoS One; 2015; 10(6):e0127702. PubMed ID: 26106884
[TBL] [Abstract][Full Text] [Related]
99. Detection of Alpha-Methylacyl-CoA Racemase (AMACR), a Biomarker of Prostate Cancer, in Patient Blood Samples Using a Nanoparticle Electrochemical Biosensor.
Lin PY; Cheng KL; McGuffin-Cawley JD; Shieu FS; Samia AC; Gupta S; Cooney M; Thompson CL; Liu CC
Biosensors (Basel); 2012 Sep; 2(4):377-87. PubMed ID: 25586028
[TBL] [Abstract][Full Text] [Related]
100. DLC1 suppresses NF-κB activity in prostate cancer cells due to its stabilizing effect on adherens junctions.
Tripathi V; Popescu NC; Zimonjic DB
Springerplus; 2014; 3():27. PubMed ID: 24683532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
